Skip to main content

CORRECTION article

Front. Pharmacol., 25 February 2016
Sec. Neuropharmacology
Volume 7 - 2016 | https://doi.org/10.3389/fphar.2016.00046
This article is part of the Research Topic Monitoring endogenous GPCRs : lessons for drug design View all 13 articles

Corrigendum: A PKA activity sensor for quantitative analysis of endogenous GPCR signaling via 2-photon FRET-FLIM imaging

This article is a correction to:

  1. A PKA activity sensor for quantitative analysis of endogenous GPCR signaling via 2-photon FRET-FLIM imaging

    1. Read original article
\r\nYao Chen,Yao Chen1,2Jessica L. Saulnier,Jessica L. Saulnier1,2Gary YellenGary Yellen2Bernardo L. Sabatini,*Bernardo L. Sabatini1,2*
  • 1Howard Hughes Medical Institute, Boston, MA, USA
  • 2Department of Neurobiology, Harvard Medical School, Boston, MA, USA

A commentary on
A PKA activity sensor for quantitative analysis of endogenous GPCR signaling via 2-photon FRET-FLIM imaging

by Chen, Y., Saulnier, J. L., Yellen, G., and Sabatini, B. L. (2014). Front. Pharmacol. 5:56. doi: 10.3389/fphar.2014.00056

Reason for Corrigendum:

There was an error in the Materials and Methods section, subsection In utero Electroporation of our Original Research article “A PKA activity sensor for quantitative analysis of endogenous GPCR signaling via 2-photon FRET-FLIM imaging.” The round plate electrodes were 5 mm in diameter, instead of 0.5 mm as stated before.

The authors apologize for the mistake.

This error does not change the scientific conclusions of the article in any way.

Author Contributions

YC wrote the Corrigendum. All authors agree to the request for changes.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: PKA, FLIM, neuromodulation, cAMP, FLIM-AKAR, GPCR, glutamate, dendritic spine

Citation: Chen Y, Saulnier JL, Yellen G and Sabatini BL (2016) Corrigendum: A PKA activity sensor for quantitative analysis of endogenous GPCR signaling via 2-photon FRET-FLIM imaging. Front. Pharmacol. 7:46. doi: 10.3389/fphar.2016.00046

Received: 17 February 2016; Accepted: 18 February 2016;
Published: 25 February 2016.

Edited and reviewed by: Dominique Massotte, Institut des Neurosciences Cellulaires et Intégratives, France

Copyright © 2016 Chen, Saulnier, Yellen and Sabatini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Bernardo L. Sabatini, bernardo_sabatini@hms.harvard.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.